A retrospective study of immunochemical fecal occult blood testing for colorectal cancer detection

Clinica Chimica Acta

Volumn 411, Issue 11-12, 2010, Pages 802-805

  Oono, Yasuhiro ^a,b   Iriguchi, Yosuke ^b   Doi, Yosuke ^c   Tomino, Yasuhiro ^b   Kishi, Daisuke ^b   Oda, Johji ^b   Takayanagi, Satoshi ^b   Mizutani, Masaru ^b   Fujisaki, Tadashi ^b   Yamamura, Akihiko ^b   Hosoi, Tozo ^b   Taguchi, Hiromi ^c   Kosaka, Mieko ^c   Delgado, Pabel ^d  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^b Tokyo Metropolitan Tama Cancer Detection Center   (Japan)

^c Alfresa Pharma Corporation   (Japan)

^d Alfresa Pharma Corporation   (Japan)

Author keywords

2 day Auto iFOBT; Colorectal cancer; Immunochemical fecal occult blood testing; Screening

Indexed keywords

HEMOGLOBIN;

ADULT; AGED; ARTICLE; ASCENDING COLON; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER SCREENING; COLITIS; COLON ADENOMA; COLON CANCER; COLON MUCOSA; COLON POLYP; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; DESCENDING COLON; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD TEST; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SIGMOID; TRANSVERSE COLON; BLOOD; COLON; COLORECTAL TUMOR; COMPARATIVE STUDY; EARLY DIAGNOSIS; IMMUNOHISTOCHEMISTRY; INTESTINE MUCOSA; METABOLISM; METHODOLOGY; MIDDLE AGED; OCCULT BLOOD; PATHOLOGY; STANDARD;

ADULT; AGED; AGED, 80 AND OVER; COLON; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; MALE; MIDDLE AGED; OCCULT BLOOD; RETROSPECTIVE STUDIES;

EID: 79951961980     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2010.02.057     Document Type: Article

References (16)

1. Wan D.S. Epidemiologic trend of and strategies for colorectal cancer. Ai Zheng 2009, 28:897-902.
2. Mandel J.S., Bond J.H., Church T.R., et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993, 328:1365-1371.
3. Cole S.R., Young G.P., Esterman A., et al. A randomised trial of the impact of new faecal haemoglobin test technologies on population participation in screening for colorectal cancer. J Med Screen 2003, 10:117-122.
4. Saito H., Soma Y., Nakajima M., et al. A case-control study evaluating occult blood screening for colorectal cancer with hemoccult test and an immunochemical hemagglutination test. Oncol Rep 2000, 7:815-819.
5. Tannous B., Lee-Lewandrowski E., Sharples C., et al. Comparison of conventional guaiac to four immunochemical methods for fecal occult blood testing: Implications for clinical pratice in hospital and outpatient settings. Clin Chim Acta 2009, 400:120-122.
6. Allison J.E., Tekawa I.S., Ransom L.J., et al. A comparison of fecal occult-blood tests for colorectal-cancer screening. N Engl J Med 1996, 334:155-159.
7. Castiglione G., Zappa M., Grazzini G., et al. Immunochemical vs guaiac faecal occult blood tests in a population-based screening programme for colorectal cancer. Br J Cancer 1996, 74:141-144.
8. Launoy G.D., Bertrand H.J., Berchi C., et al. Evaluation of an immunochemical fecal occult blood test with automated reading in screening for colorectal cancer in a general average-risk population. Int J Cancer 2005, 115:493-496.
9. Wong W.M., Lam S.K., Cheung K.L., et al. Evaluation of an automated immunochemical fecal occult blood test for colorectal neoplasia detection in a Chinese population. Cancer 2003, 97:2420-2424.
10. Morikawa T., Kato J., Yamaji Y., et al. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology 2005, 129:422-428.
11. Vilkin A., Rozen P., Levi Z., et al. Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test. Am J Gastroenterol 2005, 100:2519-2525.
12. Li S., Wang H., Hu J., et al. New immunochemical fecal occult blood test with two-consecutive stool sample testing is a cost-effective approach for colon cancer screening: results of a prospective multicenter study in Chinese patients. Int J Cancer 2006, 118:3078-3083.
13. Levi Z., Rozen P., Hazazi R., et al. A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann Intern Med 2007, 146:244-255.
14. Lohsiriwat V., Thavichaigarn P., Awapittaya B. A multicenter prospective study of immunochemical fecal occult blood testing for colorectal cancer detection. J Med Assoc Thai 2007, 90:2291-2295.
15. Saito H. Screening for colorectal cancer: current status in Japan. Dis Colon Rectum 2000, 43:S78-S84.
16. Winawer S., Fletcher R., Rex D., et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. Gastroenterol 2003, 124:544-560.